37:
30:
243:
293:
372:
148:
140:
181:
191:
246:
15:
297:
153:
128:
108:
103:
98:
93:
88:
83:
78:
73:
123:
118:
60:
366:
307:
251:
256:
51:
47:
229:
221:
174:
263:
236:
214:
273:
206:
68:
335:
will show the template collapsed, i.e. hidden apart from its title bar.
300:), it is hidden apart from its title bar; if not, it is fully visible.
268:
292:, meaning that if there is another collapsible item on the page (a
199:
19:
359:
will show the template expanded, i.e. fully visible.
338:
314:
162:
139:
59:
303:To change this template's initial visibility, the
31:
8:
38:
24:
16:
287:initial visibility currently defaults to
304:
7:
343:Drugs for treatment of bone diseases
319:Drugs for treatment of bone diseases
298:table with the collapsible attribute
244:Parathyroid hormone-related protein
14:
1:
141:Bone morphogenetic proteins
389:
182:Aluminium chlorohydrate
46:Drugs for treatment of
187:Dual action bone agent
373:Drug templates by ATC
170:Resorption inhibitor
192:Strontium ranelate
282:
281:
380:
358:
357:
353:
350:
347:
344:
341:
334:
333:
329:
326:
323:
320:
317:
306:
305:|state=
290:
285:This template's
115:Non-nitrogenous
40:
33:
26:
17:
388:
387:
383:
382:
381:
379:
378:
377:
363:
362:
355:
351:
348:
345:
342:
339:
331:
327:
324:
321:
318:
315:
294:navbox, sidebar
288:
283:
278:
158:
154:Eptotermin alfa
149:Dibotermin alfa
135:
129:Tiludronic acid
109:Zoledronic acid
104:Risedronic acid
99:Pamidronic acid
94:Neridronic acid
89:Minodronic acid
84:Incadronic acid
79:Ibandronic acid
74:Alendronic acid
61:Bisphosphonates
55:
44:
12:
11:
5:
386:
384:
376:
375:
365:
364:
361:
360:
336:
280:
279:
277:
276:
271:
266:
261:
260:
259:
254:
241:
240:
239:
226:
225:
224:
211:
210:
209:
196:
195:
194:
184:
179:
178:
177:
166:
164:
160:
159:
157:
156:
151:
145:
143:
137:
136:
134:
133:
132:
131:
126:
124:Clodronic acid
121:
119:Etidronic acid
113:
112:
111:
106:
101:
96:
91:
86:
81:
76:
65:
63:
57:
56:
45:
43:
42:
35:
28:
20:
13:
10:
9:
6:
4:
3:
2:
385:
374:
371:
370:
368:
337:
313:
312:
311:
310:may be used:
309:
301:
299:
295:
291:
275:
272:
270:
267:
265:
262:
258:
255:
253:
252:Abaloparatide
250:
249:
248:
245:
242:
238:
235:
234:
233:
231:
227:
223:
220:
219:
218:
216:
212:
208:
205:
204:
203:
201:
197:
193:
190:
189:
188:
185:
183:
180:
176:
173:
172:
171:
168:
167:
165:
161:
155:
152:
150:
147:
146:
144:
142:
138:
130:
127:
125:
122:
120:
117:
116:
114:
110:
107:
105:
102:
100:
97:
95:
92:
90:
87:
85:
82:
80:
77:
75:
72:
71:
70:
67:
66:
64:
62:
58:
53:
49:
48:bone diseases
41:
36:
34:
29:
27:
22:
21:
18:
302:
289:autocollapse
286:
284:
257:Teriparatide
228:
213:
198:
186:
169:
23:
230:Cathepsin K
222:Romosozumab
175:Ipriflavone
69:Nitrogenous
264:Calcitonin
237:Odanacatib
215:Sclerostin
330:collapsed
308:parameter
274:Vitamin D
247:analogues
232:inhibitor
217:inhibitor
207:Denosumab
202:inhibitor
367:Category
354:expanded
269:Calcium
349:state
325:state
296:, or
200:RANKL
163:Other
52:M05
369::
356:}}
340:{{
332:}}
316:{{
352:=
346:|
328:=
322:|
54:)
50:(
39:e
32:t
25:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.